Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Brown Ammonium Mixture, also known as Compound Ammonium Chloride and Glycyrrhiza Oral Solution, is a compound oral pharmaceutical preparation primarily used as an expectorant and antitussive. Its main active ingredients include ammonium chloride and glycyrrhiza (licorice) extract, often combined with other components such as camphor, anhydrous morphine, or guaifenesin. Ammonium chloride works by irritating the gastric mucosa to reflexively increase bronchial secretions, thereby thinning mucus and making it easier to expel. Glycyrrhiza extract provides a soothing effect on the pharyngeal mucosa and helps suppress cough. This mixture is commonly used to alleviate cough and discomfort associated with upper respiratory tract infections, bronchitis, and colds. It is often prepared as a hospital-made formulation, notably by Beijing Union Medical College Hospital.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Brown Ammonium Mixture.